These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14263430)

  • 21. [MALIGNANT PRIMARY URETERAL TUMORS].
    BANKE L
    Ugeskr Laeger; 1964 Mar; 126():392-5. PubMed ID: 14142331
    [No Abstract]   [Full Text] [Related]  

  • 22. A STUDY OF THE ROLE OF PROTEINORRHOEA (PROTEIN-LOSING GASTRO-ENTEROPATHY) IN BILHARZIAL HEPATIC FIBROSIS.
    EL-SAYED M; FIKRY E
    Gut; 1964 Feb; 5(1):68-70. PubMed ID: 14127512
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiopulmonary schistosomiasis.
    RODRIGUEZ HF; FERNANDEZ-DURAN A; GARCIA-MOLINER L; RIVERA E
    Am Heart J; 1963 Feb; 65():253-60. PubMed ID: 13974664
    [No Abstract]   [Full Text] [Related]  

  • 24. The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis.
    el-Raghy I; Back DJ; Osman F; Nafeh MA; Orme ML
    Br J Clin Pharmacol; 1985 Oct; 20(4):313-6. PubMed ID: 4074599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of treatment on the development and course of murine hepato-splenic schistosomiasis mansoni.
    WARREN KS
    Trans R Soc Trop Med Hyg; 1962 Nov; 56():510-9. PubMed ID: 13998984
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibronectin, platelet factor 4 and beta-thromboglobulin in endemic hepatosplenic schistosomiasis: relation to acute hematemesis.
    el-Bassiouni NE; el Bassiouny AE; Akl MM; el-Khayat HR
    Haemostasis; 1997; 27(1):39-48. PubMed ID: 9097085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GASTROESOPHAGEAL DECONGESTION AND SPLENECTOMY. A METHOD OF PREVENTION AND TREATMENT OF BLEEDING FROM ESOPHAGEAL VARICES ASSOCIATED WITH BILHARZIAL HEPATIC FIBROSIS: PRELIMINARY REPORT.
    HASSAB MA
    J Int Coll Surg; 1964 Mar; 41():232-48. PubMed ID: 14128327
    [No Abstract]   [Full Text] [Related]  

  • 28. PUNCH BIOPSY OF THE LIVER: ITS DIAGNOSTIC VALUE, WITH SPECIAL REFERENCE TO PRIMARY CANCER OF THE LIVER.
    TORRES FO
    S Afr J Med Sci; 1964 Jul; 29():1-10. PubMed ID: 14235196
    [No Abstract]   [Full Text] [Related]  

  • 29. THE SERUM CHOLINESTERASE LEVELS IN BILHARZIASIS.
    SHAKIR MH; SAIF M; ABDEL-FATTAH F
    J Egypt Med Assoc; 1964; 47():122-6. PubMed ID: 14162542
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of schistosomiasis and type B hepatitis in the pathogenesis of endemic Egyptian hepatosplenomegaly.
    Zakaria S; Mabrouk MA; Zakaria MS; Ismail MM; Khalil AM; el Kaluoby A; Kamel M; el Garem AH
    J Egypt Soc Parasitol; 1988 Dec; 18(2):421-9. PubMed ID: 3418141
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies of liver biopsies by the transparency and the histopathological techniques for the diagnosis of the bilharzial nature of 96 cases of endemic hepatosplenomegaly.
    Shoeb SM; Basmy K; Habib MA; Aidaros SM
    J Egypt Med Assoc; 1966; 49(5):347-55. PubMed ID: 5955030
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatic schistosomiasis with massive splenomegaly: a case report and literature review.
    Thijs L; Messiaen P; van der Hilst J; Madoe V; Melis C; Van Eyken P; Vanmoerkerke I; Janssens F
    Acta Gastroenterol Belg; 2018; 81(1):93-96. PubMed ID: 29562382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathology and pathogenesis of the hepatosplenic disease associated with schistosomiasis; Egyptian splenomegaly.
    HAMILTON PK; HUTCHISON HS; JAMISON PW; JONES HL
    Am J Clin Pathol; 1959 Jul; 32(1):18-33. PubMed ID: 13661118
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic value of free fatty acids in endemic hepatosplenomegaly.
    el-Hawey AM; Wahib AA; Masood AM; Gaballah AM; Abdou EA
    J Egypt Soc Parasitol; 1987 Dec; 17(2):733-40. PubMed ID: 3121770
    [No Abstract]   [Full Text] [Related]  

  • 35. LIVER CIRRHOSIS AND SCHISTOSOMIASIS INFECTION.
    SHALSHA KG
    Proc Rudolf Virchow Med Soc City N Y; 1963; 22():107-12. PubMed ID: 14277733
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of cytokeratin 18 as a biomarker of mouse and human hepatosplenic schistosomiasis.
    Manivannan B; Rawson P; Jordan TW; Karanja DM; Mwinzi PN; Secor WE; La Flamme AC
    Infect Immun; 2011 May; 79(5):2051-8. PubMed ID: 21357724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatosplenic schistosomiasis in Kenya: an assessment of the enzyme-linked immunosorbent assay (ELISA).
    de Cock KM; Hodgen AN; Lillywhite JE; Siongok TK; Lucas SB; Rees PH
    Trop Geogr Med; 1985 Dec; 37(4):285-90. PubMed ID: 4095765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell mediated immune (CMI) responsiveness to soluble egg antigen (SEA) and its relation to the occurrence of schistosomal hepatosplenic disease in patients with schistosomiasis mansoni.
    Helmy-Khalil S; Fahmy MH; Ghanem MH; Said M; El Sawy M; Nofal M; Awadalla HN; Youssef M; Mucke D; Brock J
    Tropenmed Parasitol; 1979 Dec; 30(4):426-8. PubMed ID: 538816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research on ascites in schistosomal hepatic cirrhosis].
    EL-GHAFFAR YA
    Epatologia; 1963; 9():19-29. PubMed ID: 13960604
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatosplenic disorders in schistosomiasis (author's transl)].
    Aubry P; Capdevielle P; Durand G
    Med Trop (Mars); 1980; 40(1):53-7. PubMed ID: 7366366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.